{
    "organizations": [],
    "uuid": "7025d2838200cf3fc8729536d3e2a4aa3e3ea78b",
    "author": "Peter Loftus",
    "url": "https://www.wsj.com/articles/incyte-shares-tumble-after-cancer-drug-fails-in-trial-with-mercks-keytruda-1523032878",
    "ord_in_thread": 0,
    "title": "Incyte Shares Tumble After Cancer Drug Fails in Trial With Merck’s Keytruda",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Incyte Corp. said its experimental cancer drug failed in a closely watched clinical trial that paired it with Merck & Co.’s Keytruda, striking a blow to combination therapies and sending Incyte and other biotech stocks plummeting Friday.\nIncyte’s drug, epacadostat, was previously viewed as one of the more promising of the next generation of cancer drugs designed to work by harnessing the patients’ own immune systems to destroy tumor cells. \n...  ",
    "published": "2018-04-06T20:41:00.000+03:00",
    "crawled": "2018-04-06T21:45:20.060+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "incyte",
        "said",
        "experimental",
        "cancer",
        "drug",
        "failed",
        "closely",
        "watched",
        "clinical",
        "trial",
        "paired",
        "merck",
        "keytruda",
        "striking",
        "blow",
        "combination",
        "therapy",
        "sending",
        "incyte",
        "biotech",
        "stock",
        "plummeting",
        "friday",
        "incyte",
        "drug",
        "epacadostat",
        "previously",
        "viewed",
        "one",
        "promising",
        "next",
        "generation",
        "cancer",
        "drug",
        "designed",
        "work",
        "harnessing",
        "patient",
        "immune",
        "system",
        "destroy",
        "tumor",
        "cell"
    ]
}